Postinflammatory hyperpigmentation
Postinflammatory hyperpigmentation የቆዳ በሽታ መከሰትን ተከትሎ በቆዳው ላይ ቀለም በመጨመሩ የሚታወቅ የቆዳ በሽታ ነው። postinflammatory hyperpigmentation ለረጅም ጊዜ ለፀሀይ ተጋላጭነት፣ ብግነት ወይም ሌሎች የቆዳ ጉዳቶች፣ ከብጉር ጋር የተያያዙትን ጨምሮ ሊከሰት ይችላል። ጠቆር ያለ የቆዳ ቀለም ያላቸው ሰዎች ብዙውን ጊዜ ከመጠን በላይ የፀሐይ መጋለጥ ለ hyperpigmentation በጣም የተጋለጡ ናቸው።
☆ እ.ኤ.አ. በ 2022 ከጀርመን የስቲፍቱንግ ዋረንቴስት ውጤቶች ፣ በሞዴልደርም የተገልጋዮች እርካታ ከሚከፈልባቸው የቴሌሜዲኬን ምክሮች በትንሹ ያነሰ ነበር።
References
Postinflammatory hyperpigmentation (PIH) ከቆዳ እብጠት ወይም ጉዳት በኋላ የሚከሰት ተደጋጋሚ የቆዳ ችግር ነው። ረዘም ላለ ጊዜ የመቆየት አዝማሚያ እና ጥቁር የቆዳ ቀለም ባላቸው ሰዎች (Fitzpatrick skin types III–VI) ላይ የከፋ ነው. ምንም እንኳን ብዙ ጊዜ በራሱ ይሻላል, ይህ ትንሽ ጊዜ ሊወስድ ይችላል, ስለዚህ ህክምና ብዙ ጊዜ ለረጅም ጊዜ ያስፈልጋል. የተለያዩ ህክምናዎችን ማጣመር የተሻለ ይሰራል.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation (PIH) is a common acquired cutaneous disorder occurring after skin inflammation or injury. It is chronic and is more common and severe in darker-skinned individuals (Fitzpatrick skin types III–VI). While the condition typically improves spontaneously, this process can take months to years, necessitating prolonged treatment. Combination therapy is the most effective.
Postinflammatory hyperpigmentation የተለመደ የቆዳ መቆጣት ተከታይ ነው። ጠቆር ያለ ቆዳ ያላቸው ግለሰቦችን በከፋ እና በተደጋጋሚ የመነካት አዝማሚያ አለው። ጥናቶች እንደሚያሳዩት እንደ postinflammatory hyperpigmentation ያሉ ጉዳዮች ጥቁር የቆዳ ቀለም ያላቸው ሰዎች የቆዳ ህክምና እንዲፈልጉ ከሚያደርጉት ዋና ዋና ምክንያቶች መካከል ናቸው። ቅድመ ህክምና postinflammatory hyperpigmentation ለመፍታት ወሳኝ ነው እና ብዙውን ጊዜ የሚጀምረው የመጀመሪያውን እብጠት ሁኔታን በማስተዳደር ነው። የመጀመርያው የሕክምና መስመር በተለይ ቆዳን ከፀሐይ መከላከያ ጋር የሚያቀልሉ የአካባቢ ወኪሎችን መጠቀምን ያካትታል። እነዚህ ወኪሎች ልክ እንደ hydroquinone, azelaic acid, kojic acid, arbutin, licorice extracts ከመጠን በላይ የሆነ ቀለምን በትክክል ይቀንሳሉ. በተጨማሪም፣ retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, soy እንደ ቀለም ገላጭ ወኪሎች ጥቅም ላይ ይውላሉ፣ አዳዲስ ህክምናዎች እየመጡ ነው። ወቅታዊ ህክምናዎች አብዛኛውን ጊዜ ለላይ-ደረጃ hyperpigmentation ውጤታማ ሲሆኑ፣ ግትር ለሆኑ ጉዳዮች (laser, chemical peel) ሂደቶች አስፈላጊ ሊሆኑ ይችላሉ። የ postinflammatory hyperpigmentation ብስጭት እና ብስጭት ለማስወገድ በእነዚህ ህክምናዎች ጥንቃቄ ማድረግ አስፈላጊ ነው።
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses that tends to affect darker skinned patients with greater frequency and severity. Epidemiological studies show that dyschromias, including postinflammatory hyperpigmentation, are among the most common reasons darker racial/ethnic groups seek the care of a dermatologist. The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition. First-line therapy typically consists of topical depigmenting agents in addition to photoprotection including a sunscreen. Topical tyrosinase inhibitors, such as hydroquinone, azelaic acid, kojic acid, arbutin, and certain licorice extracts, can effectively lighten areas of hypermelanosis. Other depigmenting agents include retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, and soy with a number of emerging therapies on the horizon. Topical therapy is typically effective for epidermal postinflammatory hyperpigmentation; however, certain procedures, such as chemical peeling and laser therapy, may help treat recalcitrant hyperpigmentation. It is also important to use caution with all of the above treatments to prevent irritation and worsening of postinflammatory hyperpigmentation.
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses that tends to affect darker skinned patients with greater frequency and severity. Epidemiological studies show that dyschromias, including postinflammatory hyperpigmentation, are among the most common reasons darker racial/ethnic groups seek the care of a dermatologist. The treatment of postinflammatory hyperpigmentation should be started early to help hasten its resolution and begins with management of the initial inflammatory condition. First-line therapy typically consists of topical depigmenting agents in addition to photoprotection including a sunscreen. Topical tyrosinase inhibitors, such as hydroquinone, azelaic acid, kojic acid, arbutin, and certain licorice extracts, can effectively lighten areas of hypermelanosis. Other depigmenting agents include retinoids, mequinol, ascorbic acid, niacinamide, N-acetyl glucosamine, and soy with a number of emerging therapies on the horizon. Topical therapy is typically effective for epidermal postinflammatory hyperpigmentation; however, certain procedures, such as chemical peeling and laser therapy, may help treat recalcitrant hyperpigmentation. It is also important to use caution with all of the above treatments to prevent irritation and worsening of postinflammatory hyperpigmentation.
